menu search

arcutis announces third quarter 2023 financial results and provides business update

Achieved total revenues of $38.1 million in the third quarter of 2023. Net product revenues for ZORYVE® (roflumilast) cream 0.3% were $8.1 million, a...

November 3, 2023, 11:30 am

Down -50.77% in 4 weeks, here's why you should you buy the dip in arcutis biotherapeutics, inc. (arqt)

arcutis Biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaus...

November 1, 2023, 11:21 am

arcutis biotherapeutics, inc. (arqt) loses -51.27% in 4 weeks, here's why a trend reversal may be around the corner

The heavy selling pressure might have exhausted for arcutis Biotherapeutics, Inc. (ARQT) as it is techn...

October 31, 2023, 11:21 am

arcutis to report third quarter 2023 financial results

arcutis will host a conference call and webcast at 8:30 a.m. ET on 11/3/2023 to report its third quarte...

October 25, 2023, 4:00 pm

arcutis biotherapeutics shares sink on $100m stock sale

arcutis Biotherapeutics Inc shares slid more than 18% in pre-market trading on Friday after the early c...

October 20, 2023, 9:13 am

arcutis announces pricing of $100 million public offering

WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — arcutis Biotherapeutics, Inc. (Nasdaq: ARQ...

October 20, 2023, 3:45 am

arcutis (arqt) up on fda nod for zoryve label expansion

arcutis (ARQT) gains on receiving FDA approval for label expansion of Zoryve (roflumilast) cream 0.3% t...

October 9, 2023, 10:31 am

arcutis (arqt) files snda for zoryve in atopic dermatitis, stock up

arcutis (ARQT) submits sNDA, seeking label expansion of Zoryve (roflumilast) cream 0.15% to treat patie...

September 13, 2023, 9:46 am

Why shares of arcutis biotherapeutics fell this week

arcutis' cash position is the biggest concern for investors. The company is already seeing strong sales...

September 7, 2023, 3:08 pm

arcutis biotherapeutics, inc. (arqt) reports q2 loss, tops revenue estimates

arcutis Biotherapeutics, Inc. (ARQT) came out with a quarterly loss of $1.16 per share versus the Zacks...

August 8, 2023, 7:41 pm

arcutis to report second quarter financial results

WESTLAKE VILLAGE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- arcutis Biotherapeutics, Inc.  (Nasdaq: AR...

July 24, 2023, 4:00 pm

Why shares of arcutis biotherapeutics jumped this week

arcutis Biotherapeutics launched roflumilast in a cream form last summer to treat plaque psoriasis. The...

June 9, 2023, 5:33 pm

arcutis to present at upcoming investor conference

WESTLAKE VILLAGE, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- arcutis Biotherapeutics, Inc.  (Nasdaq: AR...

June 6, 2023, 4:00 pm

arcutis biotherapeutics, inc. (arqt) q1 2023 earnings call transcript

arcutis Biotherapeutics, Inc. (NASDAQ:ARQT ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Com...

May 13, 2023, 7:53 pm

arcutis to report first quarter financial results

WESTLAKE VILLAGE, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- arcutis Biotherapeutics, Inc.  (Nasdaq: A...

April 25, 2023, 4:00 pm

arcutis to present at upcoming investor conference

WESTLAKE VILLAGE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- arcutis Biotherapeutics, Inc. (Nasdaq: AR...

April 12, 2023, 4:45 pm

arcutis biotherapeutics, inc. (arqt) q4 2022 earnings call transcript

arcutis Biotherapeutics, Inc. (NASDAQ:ARQT ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM...

February 28, 2023, 11:12 pm

arcutis biotherapeutics: market discounting zoryve momentum

The market has discounted momentum around arcutis' Zoryve label. This looks overdone and investors appe...

February 9, 2023, 4:56 am

arcutis presents new phase 2 long-term data showing sustained efficacy and clearance for a median of 10 months with roflumilast cream in adults with chronic plaque psoriasis

During the open label trial, 57.1% of roflumilast-treated participants achieved Investigator Global Assessment (IGA) of clear or almost clear at any t...

January 14, 2023, 9:00 am

arcutis biotherapeutics, inc. (arqt) q3 2022 earnings call transcript

arcutis Biotherapeutics, Inc. (NASDAQ:ARQT ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ...

November 14, 2022, 2:36 am


Search within

Pages Search Results: